Introduction to Cannabis and the Endocannabinoid System
Raphael Mechoulam, Hebrew University, Israel
The Complex Pharmacology of Plant Cannabinoids and its Overlap with Endocannabinoid and Endocannabinoidome Signaling
Vincenzo Di Marzo, Université Laval, Quebec City, Canada, and Consiglio Nazionale delle Ricerche, Italy
Why are Clinical trials in Cannabis so Different?
Nadya Lisovoder, Galilee ClinicalBioResearch, Israel
From Pre-Clinical to Clinical, the Unique Situation of Cannabis?
Dedi Meiri, Technion Institute of Technology, Israel
How to Build a Clinical Trial?
Rachel Jaros, Cann Pharmaceutical Australia Ltd, New Zealand
Basic Pharmacology and Pharmacokinetics
Rosemary Mazanet, Columbia Care & Apelles Investment Management LP, USA
Regulatory and Legal Trends in Cannabinoid Drug Development
Michael Dor, Ministry of Health, Israel
Cannabis for Chronic Pain
Elon Eisenberg, Technion Institute of Technology & Rambam Medical Center, Israel
Cannabis as an Anti-Cancer Option
Tamara Lah Turnšek, National Institute of Biology (NIB), Slovenia
Health Outcomes of the Canadian Medical Cannabis User
Jason Dyck, Univeristy of Alberta, Canada
Listening to Doctors, Listening to Patients – Is It Important?
Silviu Brill, Tel Aviv Medical Center, Israel
Cannabis in the Age of Internet-Based Medicine and E-Health
Benjamin Viaris de Lesegno, St George’s Hospital & Laso Ltd, UK
Conducting Cannabis Trials in the UK
Marcia Schofield, Cardiff University, UK
From Jamaica to UK – Baby Steps Towards Medicalization
Alexandra Chong, Jacana, UK
Keeping the Entourage with Evidence Based Data
Jeffrey Hergenrather, Society of Cannabis Clinicians, Medical Cannabis Consultant, USA
Clinical Trials as a Vehicle to Cannabinoid Based Pharmaceutical Products for Medical Markets in the EU
Roby Zomer, MGC Pharmaceuticals Ltd, Australia
What Do You Do When You Don’t Have Good Evidence?
Bonni Goldstein, Canna-Centers Wellness & Education, USA
